Klotho Neurosciences, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Klotho Neurosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2022 to Q1 2024.
  • Klotho Neurosciences, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $49.1K, a 80.8% decline year-over-year.
  • Klotho Neurosciences, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $484K.
  • Klotho Neurosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $691K, a 114% increase from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $484K $49.1K -$207K -80.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-23
Q4 2023 $691K $112K Oct 1, 2023 Dec 31, 2023 10-K 2024-04-17
Q3 2023 $149K +$69.1K +86.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-17
Q2 2023 $174K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $256K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-23
Q3 2022 $79.8K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.